Thrombomodulin Alfa for Acute Exacerbation of Idiopathic Pulmonary Fibrosis. A Randomized, Double-Blind Placebo-controlled Trial

American Journal of Respiratory and Critical Care Medicine ◽

10.1164/rccm.201909-1818oc ◽

2020 ◽

Vol 201 (9) ◽

pp. 1110-1119 ◽

Author(s):

Yasuhiro Kondoh ◽

Arata Azuma ◽

Yoshikazu Inoue ◽

Takashi Ogura ◽

Susumu Sakamoto ◽

...

Keyword(s):

Idiopathic Pulmonary Fibrosis ◽

Pulmonary Fibrosis ◽

Acute Exacerbation ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Pamrevlumab (FG-3019), an Anti-Connective Tissue Growth Factor Therapy for Idiopathic Pulmonary Fibrosis: A Randomized, Double-Blind, Placebo-Controlled Trial

SSRN Electronic Journal ◽

10.2139/ssrn.3379814 ◽

2019 ◽

Author(s):

Luca Richeldi ◽

Evans R. Fernández Pérez ◽

Ulrich Costabel ◽

Carlo Albera ◽

David J. Lederer ◽

...

Keyword(s):

Growth Factor ◽

Idiopathic Pulmonary Fibrosis ◽

Connective Tissue ◽

Pulmonary Fibrosis ◽

Controlled Trial ◽

Tissue Growth ◽

Double Blind ◽

Double Blind Placebo ◽

Factor Therapy ◽

Growth Factor Therapy

Download Full-text

Study protocol: exploring the efficacy of cyclophosphamide added to corticosteroids for treating acute exacerbation of idiopathic pulmonary fibrosis; a randomized double-blind, placebo-controlled, multi-center phase III trial (EXAFIP)

BMC Pulmonary Medicine ◽

10.1186/s12890-019-0830-x ◽

2019 ◽

Vol 19 (1) ◽

Author(s):

Jean-Marc Naccache ◽

Melissa Montil ◽

Jacques Cadranel ◽

Marine Cachanado ◽

Vincent Cottin ◽

...

Keyword(s):

Idiopathic Pulmonary Fibrosis ◽

Pulmonary Fibrosis ◽

Acute Exacerbation ◽

Study Protocol ◽

Phase Iii ◽

Double Blind ◽

Phase Iii Trial ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718270310.793490583 ◽

2014 ◽

Author(s):

Toby Maher

Keyword(s):

Idiopathic Pulmonary Fibrosis ◽

Pulmonary Fibrosis ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trial

The Lancet Respiratory Medicine ◽

10.1016/s2213-2600(21)00354-4 ◽

2021 ◽

Author(s):

Jean-Marc Naccache ◽

Stéphane Jouneau ◽

Morgane Didier ◽

Raphaël Borie ◽

Marine Cachanado ◽

...

Keyword(s):

Idiopathic Pulmonary Fibrosis ◽

Pulmonary Fibrosis ◽

Acute Exacerbation ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Double-blind, Placebo-controlled Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

American Journal of Respiratory and Critical Care Medicine ◽

10.1164/rccm.200404-571oc ◽

2005 ◽

Vol 171 (9) ◽

pp. 1040-1047 ◽

Author(s):

Arata Azuma ◽

Toshihiro Nukiwa ◽

Eiyasu Tsuboi ◽

Moritaka Suga ◽

Shosaku Abe ◽

...

Keyword(s):

Idiopathic Pulmonary Fibrosis ◽

Pulmonary Fibrosis ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Efficacy And Safety Of Macitentan In Idiopathic Pulmonary Fibrosis: Results Of A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial

10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a3631 ◽

2012 ◽

Author(s):

Ganesh Raghu ◽

Rachel Million-Rousseau ◽

Adele Morganti ◽

Loïc Perchenet ◽

Juergen Behr

Keyword(s):

Idiopathic Pulmonary Fibrosis ◽

Pulmonary Fibrosis ◽

Controlled Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

RCT Abstract - Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomized, double-blind, placebo-controlled, phase 3 trial

10.1183/13993003.congress-2021.rct2903 ◽

2021 ◽

Author(s):

Jean-Marc Naccache ◽

Stephane Jouneau ◽

Morgane Didier ◽

Raphaël Borie ◽

Marine Cachanado ◽

...

Keyword(s):

Idiopathic Pulmonary Fibrosis ◽

Pulmonary Fibrosis ◽

Acute Exacerbation ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

A Randomized, Double-blind, Multicentre, Controlled Trial Of Inhaled N-Acetylcysteine In Patients With The Early Stage Of Idiopathic Pulmonary Fibrosis In Japan

10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a3986 ◽

2010 ◽

Author(s):

Sakae A. Homma ◽

Arata Azuma ◽

Hiroyuki Taniguchi ◽

Takashi Ogura ◽

Yoshiro Mochizuki ◽

...

Keyword(s):

Idiopathic Pulmonary Fibrosis ◽

Pulmonary Fibrosis ◽

Early Stage ◽

Controlled Trial ◽

Download Full-text

S91 A randomised, double-blind, placebo-controlled crossover study to assess the efficacy of a single dose of 100 mg of VRP700 by inhalation in reducing the frequency and severity of cough in adult patients with Idiopathic Pulmonary Fibrosis

Thorax ◽

10.1136/thoraxjnl-2015-207770.97 ◽

2015 ◽

Vol 70 (Suppl 3) ◽

pp. A52.1-A52 ◽

Author(s):

I Satia ◽

H Badri ◽

R Dockry ◽

N Chaudhuri ◽

G Brown ◽

...

Keyword(s):

Single Dose ◽

Idiopathic Pulmonary Fibrosis ◽

Pulmonary Fibrosis ◽

Crossover Study ◽

Adult Patients ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

A Randomized, Double-Blind, Placebo-Controlled Trial of Aripiprazole Lauroxil in Acute Exacerbation of Schizophrenia

The Journal of Clinical Psychiatry ◽

10.4088/jcp.14m09741 ◽

2015 ◽

Vol 76 (08) ◽

pp. 1085-1090 ◽

Author(s):

Herbert Y. Meltzer ◽

Robert Risinger ◽

Henry A. Nasrallah ◽

Yangchun Du ◽

Jacqueline Zummo ◽

...

Keyword(s):

Acute Exacerbation ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo

Download Full-text